RAYMOND JAMES & ASSOCIATES - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 991 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$31,447,395
-24.4%
833,265
-8.7%
0.03%
-23.5%
Q2 2023$41,587,327
+10.9%
912,805
-1.3%
0.03%
+3.0%
Q1 2023$37,512,011
-53.7%
924,854
-41.8%
0.03%
-55.4%
Q4 2022$81,064,325
+11.6%
1,590,431
+18.0%
0.07%
+1.4%
Q3 2022$72,607,000
-9.9%
1,348,074
+7.5%
0.07%
-7.6%
Q2 2022$80,573,000
-13.9%
1,254,443
+3.9%
0.08%0.0%
Q1 2022$93,594,000
+6.0%
1,207,039
+17.3%
0.08%
+11.3%
Q4 2021$88,309,000
+22.2%
1,028,770
+14.5%
0.07%
+9.2%
Q3 2021$72,252,000
+107.0%
898,327
+107.2%
0.06%
+103.1%
Q2 2021$34,896,000
+14.6%
433,485
+20.1%
0.03%
+3.2%
Q1 2021$30,442,000
+49.5%
360,949
+42.3%
0.03%
+40.9%
Q4 2020$20,358,000
+22.5%
253,718
+22.8%
0.02%
+4.8%
Q3 2020$16,615,000
-22.1%
206,598
-16.6%
0.02%
-27.6%
Q2 2020$21,326,000
-4.4%
247,691
-9.9%
0.03%
-17.1%
Q1 2020$22,311,000
-8.7%
274,799
-6.0%
0.04%
+12.9%
Q4 2019$24,437,000
-12.6%
292,241
-8.5%
0.03%
-20.5%
Q3 2019$27,944,000
+23.4%
319,466
+15.6%
0.04%
+18.2%
Q2 2019$22,640,000
-10.5%
276,444
-11.1%
0.03%
-13.2%
Q1 2019$25,287,000
+52.1%
310,997
+23.1%
0.04%
+31.0%
Q4 2018$16,629,000
-28.1%
252,650
-15.8%
0.03%
-19.4%
Q3 2018$23,124,000
-0.3%
299,968
-4.5%
0.04%
-7.7%
Q2 2018$23,193,000
+33.6%
314,101
+17.7%
0.04%
+25.8%
Q1 2018$17,363,000
+19.0%
266,965
+18.3%
0.03%
+14.8%
Q4 2017$14,588,000
+22.5%
225,680
+18.9%
0.03%
+12.5%
Q3 2017$11,911,000
+2.8%
189,812
-0.8%
0.02%
-4.0%
Q2 2017$11,585,000
+23.7%
191,363
+6.0%
0.02%
+13.6%
Q1 2017$9,362,000
+43.2%
180,521
+22.4%
0.02%
+29.4%
Q4 2016$6,539,000
-28.8%
147,479
-23.6%
0.02%
-32.0%
Q3 2016$9,188,000
+26.2%
193,021
+19.9%
0.02%
+8.7%
Q2 2016$7,280,000
-34.7%
160,993
-40.7%
0.02%
-39.5%
Q1 2016$11,145,000
+28.4%
271,296
+19.2%
0.04%
+22.6%
Q4 2015$8,681,000
+16.8%
227,556
+0.6%
0.03%
+3.3%
Q3 2015$7,431,000
-66.7%
226,222
-29.2%
0.03%
-65.1%
Q2 2015$22,343,000
+5.4%
319,502
+3.2%
0.09%
-7.5%
Q1 2015$21,199,000
-0.1%
309,464
+6.9%
0.09%
-10.6%
Q4 2014$21,222,000
+19.7%
289,566
+17.2%
0.10%
+2.0%
Q3 2014$17,725,000
+12.7%
246,977
+13.5%
0.10%
+5.2%
Q2 2014$15,727,000
+22.3%
217,525
+24.5%
0.10%
+10.2%
Q1 2014$12,858,000
+1.4%
174,743
-4.2%
0.09%
-7.4%
Q4 2013$12,683,000
+20.4%
182,359
+13.7%
0.10%
+4.4%
Q3 2013$10,535,000
-10.2%
160,369
-5.3%
0.09%
-18.0%
Q2 2013$11,733,000169,3850.11%
Other shareholders
BAXTER INTL INC shareholders Q3 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 298,721$23,969,0008.70%
GENERATION INVESTMENT MANAGEMENT LLP 17,424,560$1,398,147,0006.24%
Soditic Asset Management LLP 77,950$6,255,0006.24%
Veritas Asset Management LLP 11,110,132$891,477,0005.32%
Dash Acquisitions Inc. 84,560$6,785,0004.74%
Prosight Management, LP 121,075$9,715,0004.49%
TSFG, LLC 94,977$7,621,0004.07%
CINCINNATI FINANCIAL CORP 1,344,648$107,895,0002.93%
Dundas Partners LLP 204,535$19,304,0002.82%
Unified Trust Company, N.A. 59,491$4,689,0002.72%
View complete list of BAXTER INTL INC shareholders